The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.
about
The disparate origins of ovarian cancers: pathogenesis and prevention strategies.Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinomaIn vitro and in vivo correlates of physiological and neoplastic human Fallopian tube stem cells.Serous tubal intraepithelial carcinoma (STIC) - clinical impact and management.LEF1 is preferentially expressed in the tubal-peritoneal junctions and is a reliable marker of tubal intraepithelial lesions.Iron addiction: a novel therapeutic target in ovarian cancerThe conceptual advances of carcinogenic sequence model in high-grade serous ovarian cancer.Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis.Epithelial stem cell culture: modeling human disease and applications for regenerative medicine.PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state.Origin of clear cell carcinoma: nature or nurture?PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer.Identification of candidate genes associated with tubal origin of high-grade serous ovarian cancer.UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
P2860
Q30240709-E33A08A1-4A00-4CB1-BAFB-1E3FEE4C30BCQ36103306-F025DE88-1ECB-4616-B645-40B4DD62B48EQ36976183-BD135CA3-8580-4E25-AF91-0AB2868D3E58Q38978839-8B7DD5E0-79EC-4F21-9C0D-A8BFAA9B601DQ40140028-2EDEAB3C-215A-4BAB-97DC-36A5D0300786Q41211121-B68A69E2-809B-4239-B4EF-712634DC77AAQ41294690-1427F8B5-AA4D-459E-B72B-FA637838183CQ46303839-33FFA572-F1F0-4CDD-998A-366FC4FE981CQ47143246-83DBFB40-0A98-411B-9368-41AEB235E807Q47160060-F7DCAF52-6A9F-4078-B708-0A1D0DD9A276Q48233176-A08C5E13-F464-4DD9-9175-90EC8757B17DQ51251438-FEA41803-604F-4037-9AA2-EC030D7D6DA4Q55247501-4A6830DE-0A6F-4F59-A165-2267FE4C6CA4Q58795166-05220F06-6D7C-49BC-9D4A-1AE39D1B8FBE
P2860
The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@ast
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@en
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@nl
type
label
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@ast
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@en
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@nl
prefLabel
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@ast
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@en
The PAX2-null immunophenotype ...... oplastic oviductal epithelium.
@nl
P2093
P2860
P356
P1476
The PAX2-null immunophenotype ...... eoplastic oviductal epithelium
@en
P2093
Christopher P Crum
Frank D McKeon
Jonathan G Bijron
Lingyan Wu
Maxence Cornille
Michael Herfs
Suchanan Hanamornroongruang
P2860
P304
P356
10.1002/PATH.4417
P577
2014-09-30T00:00:00Z